Nuvectis Pharma Inc (NVCT)

Nuvectis Pharma Inc (NVCT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $716M; returns 1 day -4.0%, 1 week +7.8%, 1 year +233.6%.

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing precision medicines for oncology. The company currently generates no revenue, as its business model is entirely centered on the research and development of its drug pipeline.

Groups NVCT belongs to

• Clinical Stage Biotech
• Oncology
• Biotechnology
• Biopharmaceutical
• Precision Medicine
• Healthcare
• Cancer Therapeutics
• Ovarian Cancer

NVCT financial model: income statement, cash flow and balance sheet